Page last updated: 2024-09-04

naphthalenesulfonamide and dorzolamide

naphthalenesulfonamide has been researched along with dorzolamide in 2 studies

Compound Research Comparison

Studies
(naphthalenesulfonamide)
Trials
(naphthalenesulfonamide)
Recent Studies (post-2010)
(naphthalenesulfonamide)
Studies
(dorzolamide)
Trials
(dorzolamide)
Recent Studies (post-2010) (dorzolamide)
1604836261255

Protein Interaction Comparison

ProteinTaxonomynaphthalenesulfonamide (IC50)dorzolamide (IC50)
Carbonic anhydrase 2Homo sapiens (human)0.0099
Androgen receptorHomo sapiens (human)0.065
Carbonic anhydrase 4Homo sapiens (human)0.0262
Carbonic anhydrase 9Homo sapiens (human)0.052
Carbonic anhydrase 4Bos taurus (cattle)0.043

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franchi, M; Gallori, E; Pastorek, J; Pastorekova, S; Scozzafava, A; Supuran, CT; Vullo, D1
Jaiswal, M; Khadikar, PV; Scozzafava, A; Supuran, CT1

Other Studies

2 other study(ies) available for naphthalenesulfonamide and dorzolamide

ArticleYear
Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
    Bioorganic & medicinal chemistry letters, 2003, Mar-24, Volume: 13, Issue:6

    Topics: Animals; Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Cattle; Heterocyclic Compounds; Humans; Hydrocarbons, Aromatic; Isoenzymes; Kinetics; Neoplasm Proteins; Neoplasms; Structure-Activity Relationship; Sulfonamides

2003
Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides.
    Bioorganic & medicinal chemistry letters, 2004, Jun-21, Volume: 14, Issue:12

    Topics: Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Isoenzymes; Quantitative Structure-Activity Relationship; Sulfonamides

2004